550 related articles for article (PubMed ID: 8134220)
1. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns.
Pylipow M; Gaddis M; Kinney JS
Pediatrics; 1994 Apr; 93(4):631-5. PubMed ID: 8134220
[TBL] [Abstract][Full Text] [Related]
2. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
3. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis.
Ascher DP; Becker JA; Yoder BA; Weisse M; Waecker NJ; Heroman WM; Davis C; Fajardo JE; Fischer GW
J Perinatol; 1993; 13(3):212-6. PubMed ID: 8345385
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics of group b streptococcus vertical transmission].
Andreu Domingo A; Salcedo Abizanda S; Heredia Prim F; González Morlans J; Bartolomé Comas RM; Cabero Roura L
An Esp Pediatr; 1997 Apr; 46(4):383-8. PubMed ID: 9214233
[TBL] [Abstract][Full Text] [Related]
5. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
[TBL] [Abstract][Full Text] [Related]
7. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
Pinto NM; Soskolne EI; Pearlman MD; Faix RG
J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
[TBL] [Abstract][Full Text] [Related]
8. [Colonization by group B hemolytic streptococcus in pregnancy. Note of prevention and therapy of the materno-neonatal infection. Casuistics].
Della Morte MA; Ratti E; Sala MR; Colombo B
Pediatr Med Chir; 1996; 18(5):433-50. PubMed ID: 9053881
[TBL] [Abstract][Full Text] [Related]
9. Early-onset group B Streptococcus sepsis in high risk neonates born after prolonged rupture of membranes.
Makhoul IR; Sprecher H; Sawaid R; Jakobi P; Smolkin T; Sujov P; Kassis I; Blazer S
Isr Med Assoc J; 2009 Jan; 11(1):34-8. PubMed ID: 19344010
[TBL] [Abstract][Full Text] [Related]
10. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study.
Lijoi D; Di Capua E; Ferrero S; Mistrangelo E; Giannattasio A; Morano S; Ragni N
Arch Gynecol Obstet; 2007 May; 275(5):373-9. PubMed ID: 17047973
[TBL] [Abstract][Full Text] [Related]
12. Group B Streptococcus early-onset disease in Emilia-romagna: review after introduction of a screening-based approach.
Berardi A; Lugli L; Baronciani D; Rossi C; Ciccia M; Creti R; Gambini L; Mariani S; Papa I; Tridapalli E; Vagnarelli F; Ferrari F;
Pediatr Infect Dis J; 2010 Feb; 29(2):115-21. PubMed ID: 19915512
[TBL] [Abstract][Full Text] [Related]
13. [Intrapartum administration of antibiotics in the prevention of neonatal Streptococcus B infections].
Horváth B; Grasselly M; Lakatos F; Kneffel P
Orv Hetil; 1998 Nov; 139(48):2899-901. PubMed ID: 9868905
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
[TBL] [Abstract][Full Text] [Related]
15. Intrapartum chemoprophylaxis for group B streptococcus infection to prevent neonatal disease: who should be treated?
Philipson EH; Herson VC
Am J Perinatol; 1996 Nov; 13(8):487-90. PubMed ID: 8989480
[TBL] [Abstract][Full Text] [Related]
16. Impact of intrapartum antibiotics on the care and evaluation of the neonate.
Balter S; Zell ER; O'Brien KL; Roome A; Noga H; Thayu M; Schuchat A
Pediatr Infect Dis J; 2003 Oct; 22(10):853-7. PubMed ID: 14551483
[TBL] [Abstract][Full Text] [Related]
17. Prevention of group B streptococcal disease in the newborn.
Apgar BS; Greenberg G; Yen G
Am Fam Physician; 2005 Mar; 71(5):903-10. PubMed ID: 15768620
[TBL] [Abstract][Full Text] [Related]
18. Prevention of group B streptococcal infection.
Noya FJ; Baker CJ
Infect Dis Clin North Am; 1992 Mar; 6(1):41-55. PubMed ID: 1578122
[TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with ampicillin-resistant infection in newborns in the era of group B streptococcal prophylaxis.
Rentz AC; Samore MH; Stoddard GJ; Faix RG; Byington CL
Arch Pediatr Adolesc Med; 2004 Jun; 158(6):556-60. PubMed ID: 15184219
[TBL] [Abstract][Full Text] [Related]
20. Compliance with protocols for prevention of neonatal group B streptococcal sepsis: practicalities and limitations.
Gilbert GL; Hewitt MC; Turner CM; Leeder SR
Infect Dis Obstet Gynecol; 2003; 11(1):1-9. PubMed ID: 12839627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]